Compare CORAL LAB. with RAYMED LABS. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs RAYMED LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CORAL LAB. RAYMED LABS CORAL LAB./
RAYMED LABS
 
P/E (TTM) x 9.6 -6.3 - View Chart
P/BV x 0.9 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 CORAL LAB.   RAYMED LABS
EQUITY SHARE DATA
    CORAL LAB.
Mar-21
RAYMED LABS
Mar-21
CORAL LAB./
RAYMED LABS
5-Yr Chart
Click to enlarge
High Rs4431 46,177.1%   
Low Rs951 10,000.0%   
Sales per share (Unadj.) Rs270.50-  
Earnings per share (Unadj.) Rs38.0-0.2 -23,496.9%  
Cash flow per share (Unadj.) Rs43.5-0.1 -29,499.5%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs382.8-4.8 -7,960.8%  
Shares outstanding (eoy) m3.574.27 83.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.0NM-  
Avg P/E ratio x7.1-5.9 -119.5%  
P/CF ratio (eoy) x6.2-6.5 -95.9%  
Price / Book Value ratio x0.7-0.2 -354.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m9624 23,567.8%   
No. of employees `000NANA-   
Total wages/salary Rs m1020 50,910.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m9660-  
Other income Rs m380 53,857.1%   
Total revenues Rs m1,0030 1,433,385.7%   
Gross profit Rs m161-1 -23,011.4%  
Depreciation Rs m200 33,050.0%   
Interest Rs m30-   
Profit before tax Rs m176-1 -25,524.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m410-   
Profit after tax Rs m136-1 -19,644.9%  
Gross profit margin %16.7NM- 
Effective tax rate %23.00-   
Net profit margin %14.0NM- 
BALANCE SHEET DATA
Current assets Rs m1,1081 123,160.0%   
Current liabilities Rs m27823 1,205.5%   
Net working cap to sales %86.0NM- 
Current ratio x4.00 10,216.8%  
Inventory Days Days135NM- 
Debtors Days Days1,480NM- 
Net fixed assets Rs m5672 35,214.3%   
Share capital Rs m3643 83.6%   
"Free" reserves Rs m1,331-63 -2,103.6%   
Net worth Rs m1,366-21 -6,655.8%   
Long term debt Rs m00-   
Total assets Rs m1,6753 66,483.7%  
Interest coverage x63.2NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.60-   
Return on assets %8.3-27.3 -30.3%  
Return on equity %9.93.4 295.9%  
Return on capital %13.13.4 390.8%  
Exports to sales %72.3NM-  
Imports to sales %2.0NM-  
Exports (fob) Rs m698NA-   
Imports (cif) Rs m19NA-   
Fx inflow Rs m6980-   
Fx outflow Rs m310-   
Net fx Rs m6680-   
CASH FLOW
From Operations Rs m110-  
From Investments Rs m-2NA-  
From Financial Activity Rs m3NA-  
Net Cashflow Rs m120-  

Share Holding

Indian Promoters % 32.3 28.4 113.9%  
Foreign collaborators % 39.2 0.0 -  
Indian inst/Mut Fund % 0.4 1.0 43.8%  
FIIs % 0.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 28.5 71.6 39.8%  
Shareholders   4,425 1,478 299.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CORAL LAB. With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Loses the Psychological 60,000-Mark, Dips 900 Points; Finance & IT Stocks Bleed(02:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CORAL LAB. SHARE PRICE


Jan 20, 2022 03:35 PM

TRACK CORAL LAB.

  • Track your investment in CORAL LAB. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

CORAL LAB. 8-QTR ANALYSIS

COMPARE CORAL LAB. WITH

MARKET STATS